Serum 25-hydroxyvitamin D concentrations and lung cancer risk in never-smoking postmenopausal women

[1]  Mary E Reid,et al.  The International Epidemiology of Lung Cancer: Latest Trends, Disparities, and Tumor Characteristics , 2016, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[2]  J. Manson,et al.  Update on the Vitamin D and OmegA-3 trial (VITAL) , 2016, The Journal of Steroid Biochemistry and Molecular Biology.

[3]  H. Brenner,et al.  Pre-diagnostic vitamin D concentrations and cancer risks in older individuals: an analysis of cohorts participating in the CHANCES consortium , 2016, European Journal of Epidemiology.

[4]  Ling Wang,et al.  Circulating 25-hydroxyvitamin D and risk of lung cancer: a dose–response meta-analysis , 2015, Cancer Causes & Control.

[5]  A. LaCroix,et al.  Estimated intake of vitamin D and its interaction with vitamin A on lung cancer risk among smokers , 2014, International journal of cancer.

[6]  Jennifer G. Robinson,et al.  Calcium/vitamin D supplementation, serum 25-hydroxyvitamin D concentrations, and cholesterol profiles in the Women’s Health Initiative calcium/vitamin D randomized trial , 2014, Menopause.

[7]  G. Hankey,et al.  In Older Men, Lower Plasma 25-Hydroxyvitamin D Is Associated with Reduced Incidence of Prostate, but Not Colorectal or Lung Cancer , 2014, PloS one.

[8]  A. LaCroix,et al.  Vitamin D intake determines vitamin d status of postmenopausal women, particularly those with limited sun exposure. , 2014, The Journal of nutrition.

[9]  T. Jørgensen,et al.  Prospective Population-Based Study of the Association between Serum 25-Hydroxyvitamin-D Levels and the Incidence of Specific Types of Cancer , 2014, Cancer Epidemiology, Biomarkers & Prevention.

[10]  S. Novello,et al.  Lung cancer in never smokers: a different disease , 2014, Current Respiratory Care Reports.

[11]  J. Witte,et al.  Antioxidant and vitamin E transport genes and risk of high‐grade prostate cancer and prostate cancer recurrence , 2013, The Prostate.

[12]  A. LaCroix,et al.  Vitamin D intake and lung cancer risk in the Women's Health Initiative. , 2013, The American journal of clinical nutrition.

[13]  Q. Hu,et al.  Differential response to 1α,25-dihydroxyvitamin D3 (1α,25(OH)2D3) in non-small cell lung cancer cells with distinct oncogene mutations , 2013, The Journal of Steroid Biochemistry and Molecular Biology.

[14]  S. Bojesen,et al.  Low plasma 25-hydroxyvitamin D and risk of tobacco-related cancer. , 2013, Clinical chemistry.

[15]  H. Brenner,et al.  Serum 25-Hydroxyvitamin D and Cancer Risk in Older Adults: Results from a Large German Prospective Cohort Study , 2013, Cancer Epidemiology, Biomarkers & Prevention.

[16]  M. Neuhouser,et al.  Serum 25-hydroxyvitamin D, vitamin A, and lung cancer mortality in the US population: a potential nutrient–nutrient interaction , 2012, Cancer Causes & Control.

[17]  A. Muñoz,et al.  Vitamin D and colon cancer. , 2012, Endocrine-related cancer.

[18]  R. Genco,et al.  Intraindividual Variation in Plasma 25-Hydroxyvitamin D Measures 5 Years Apart among Postmenopausal Women , 2012, Cancer Epidemiology, Biomarkers & Prevention.

[19]  A. LaCroix,et al.  The Effect of Calcium plus Vitamin D on Risk for Invasive Cancer: Results of the Women's Health Initiative (WHI) Calcium Plus Vitamin D Randomized Clinical Trial , 2011, Nutrition and cancer.

[20]  Kai Yu,et al.  Serum 25-Hydroxyvitamin D and Risk of Lung Cancer in Male Smokers: A Nested Case-Control Study , 2011, PloS one.

[21]  T. Rohan,et al.  Association of active and passive smoking with risk of breast cancer among postmenopausal women: a prospective cohort study , 2011, BMJ : British Medical Journal.

[22]  Christine L. Taylor,et al.  Dietary Reference Intakes for Calcium and Vitamin D , 2016, Pediatric Clinical Practice Guidelines & Policies.

[23]  C. Abnet,et al.  Serum 25-hydroxyvitamin D and cancer mortality in the NHANES III study (1988-2006). , 2010, Cancer research.

[24]  C. Abnet,et al.  Serum Vitamin D and Cancer Mortality in the NHANES III Study (1988–2006) , 2010 .

[25]  Erika Avila-Tang,et al.  Lung Cancer in Never Smokers: Clinical Epidemiology and Environmental Risk Factors , 2009, Clinical Cancer Research.

[26]  M. Thun,et al.  Comparing methods for accounting for seasonal variability in a biomarker when only a single sample is available: insights from simulations based on serum 25-hydroxyvitamin d. , 2009, American journal of epidemiology.

[27]  S. Bondy,et al.  Origin and use of the 100 cigarette criterion in tobacco surveys , 2009, Tobacco Control.

[28]  G. Hunninghake,et al.  Respiratory Epithelial Cells Convert Inactive Vitamin D to Its Active Form: Potential Effects on Host Defense1 , 2008, The Journal of Immunology.

[29]  A. Aromaa,et al.  Vitamin D Status and the Risk of Lung Cancer: A Cohort Study in Finland , 2008, Cancer Epidemiology Biomarkers & Prevention.

[30]  S. Lippman,et al.  Lung cancer. , 2008, The New England journal of medicine.

[31]  R. Salgia,et al.  Vitamin D Receptor Expression in Normal, Premalignant, and Malignant Human Lung Tissue , 2008, Cancer Epidemiology Biomarkers & Prevention.

[32]  E. Giovannucci.  Can vitamin D reduce total mortality? , 2007, Archives of internal medicine.

[33]  D. Trump,et al.  Vitamin D signalling pathways in cancer: potential for anticancer therapeutics , 2007, Nature Reviews Cancer.

[34]  M. Holick.  Vitamin D deficiency. , 2007, The New England journal of medicine.

[35]  W. Willett,et al.  Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. , 2006, The American journal of clinical nutrition.

[36]  Yan Liu,et al.  Prospective study of predictors of vitamin D status and cancer incidence and mortality in men. , 2006, Journal of the National Cancer Institute.

[37]  J. Manson,et al.  Calcium plus vitamin D supplementation and the risk of fractures. , 2006, The New England journal of medicine.

[38]  John Robbins,et al.  Calcium plus vitamin D supplementation and the risk of colorectal cancer. , 2006, The New England journal of medicine.

[39]  U. Kaiser,et al.  Expression of vitamin D receptor in lung cancer , 2005, Journal of Cancer Research and Clinical Oncology.

[40]  Garnet L Anderson,et al.  The Women's Health Initiative recruitment methods and results. , 2003, Annals of epidemiology.

[41]  C. Kooperberg,et al.  Outcomes ascertainment and adjudication methods in the Women's Health Initiative. , 2003, Annals of epidemiology.

[42]  D. Galuska,et al.  High Serum Retinyl Esters Are Not Associated with Reduced Bone Mineral Density in the Third National Health and Nutrition Examination Survey, 1988–1994 , 2001, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[43]  A. Kristal,et al.  Measurement characteristics of the Women's Health Initiative food frequency questionnaire. , 1999, Annals of epidemiology.

[44]  A. Kristal,et al.  Evaluation of a simplified vitamin supplement inventory developed for the Women's Health Initiative , 1999, Public Health Nutrition.

[45]  H. Cross,et al.  Mechanism of antimitogenic action of vitamin D in human colon carcinoma cells: relevance for suppression of epidermal growth factor-stimulated cell growth. , 1999, Oncology research.

[46]  JoAnn E. Manson,et al.  Design of the Women's Health Initiative clinical trial and observational study. The Women's Health Initiative Study Group. , 1998, Controlled clinical trials.

[47]  S. Greenland,et al.  Simulation study of confounder-selection strategies. , 1993, American journal of epidemiology.

[48]  C. Carlberg,et al.  Two nuclear signalling pathways for vitamin D , 1993, Nature.

[49]  R. Russell,et al.  Relationship of vitamin A and vitamin E intake to fasting plasma retinol, retinol-binding protein, retinyl esters, carotene, alpha-tocopherol, and cholesterol among elderly people and young adults: increased plasma retinyl esters among vitamin A-supplement users. , 1989, The American journal of clinical nutrition.